EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Expanding Horizons of CRISPR/Cas Technology: Clinical Advancements, Therapeutic Applications, and Challenges in Gene Therapy

Ahmad Bairqdar iD, Polina E Karitskaya iD, Grigory A Stepanov iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252413321 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Ahmad Bairqdar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Genetic Therapy, Gene Editing. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CRISPR–Cas technology has transformed the field of gene editing, opening new possibilities for treatment of various genetic disorders. Recent years have seen a surge in clinical trials using CRISPR–Cas-based therapies. This review examines the current landscape of CRISPR–Cas implementation in clinical trials, with data from key registries, including the Australian New Zealand Clinical Trials Registry, the Chinese Clinical Trial Register, and ClinicalTrials.gov. Emphasis is placed on the mechanism of action of tested therapies, the delivery method, and the most recent findings of each clinical trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Cas SystemsGenetic TherapyGene EditingHumansClinical Trials as TopicAnimals

Stichwörter der Autor:innen

CRISPR–Casgene therapygenome editingxenotransplantation

Autor:innen und Institutionen

  • Institute of Chemical Biology and Fundamental Medicine of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk 630090, Russia.
  • Department of Natural Sciences, Novosibirsk State University, Novosibirsk 630090, Russia.

ORCID-Profile: Ahmad Bairqdar, Polina E Karitskaya, Grigory A Stepanov

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Bairqdar, A., Karitskaya, P. E., & Stepanov, G. A. (2024). Expanding Horizons of CRISPR/Cas Technology: Clinical Advancements, Therapeutic Applications, and Challenges in Gene Therapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252413321

Vancouver

Bairqdar A, Karitskaya PE, Stepanov GA. Expanding Horizons of CRISPR/Cas Technology: Clinical Advancements, Therapeutic Applications, and Challenges in Gene Therapy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252413321

BibTeX
@article{Bairqdar2024,
  author = {Bairqdar, Ahmad and Karitskaya, Polina E and Stepanov, Grigory A},
  title = {Expanding Horizons of CRISPR/Cas Technology: Clinical Advancements, Therapeutic Applications, and Challenges in Gene Therapy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252413321}
}
Kostenlos starten →